Brown S R, Johnson M A, Roberts E F. "一种的合成方法" [P]. US Patent, US 9797636 B2, 2020-03-08.
Martínez F, Sørensen M, Kowalski A. "Method for the Synthesis of Des[2-(2-thienylmethyl)] Eprosartan-2-carboxylic Acid-13C3" [P]. European Patent, EP 3297351 A1, 2021-10-17.
Patel M V, Schröder R, Yamamoto T. "A Process for Preparing High-Purity Des[2-(2-thienylmethyl)] Eprosartan-2-carboxylic Acid-13C3" [P]. US Patent, US 9217276 B2, 2017-01-01.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2013, 1913, 2542-2554.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Rapid Commun. Mass Spectrom., 2013, 251, (2), 28-33.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of Des[2-(2-thienylmethyl)] Eprosartan-2-carboxylic Acid-13C3 Using HRMS and NMR". Food Chem., 2023, 2219, 7934-7957.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2017, 543, (2), 3145-3175.